BCL2L1 and Thrombocytopenia: Our data suggest that Bcl-XL inhibition could be an efficacious strategy to improve the toxicity of Aurora A and B inhibitors, but it is essential to avoid thrombocytopenia associated with the blockade of this anti-apoptotic protein [53].